{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"AcelRx Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"ACRX"},"Address":{"label":"Address","value":"25821 INDUSTRIAL BOULEVARD SUITE 400, HAYWARD, California, 94545, United States"},"Phone":{"label":"Phone","value":"+1 650 216-3500"},"Industry":{"label":"Industry","value":" Medicinal Chemicals and Botanical Products "},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.acelrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Badri N. Dasu","title":"Chief Engineering Officer"},{"name":"Pamela Pierce Palmer","title":"Director &amp; Chief Medical Officer"},{"name":"Vincent J. Angotti","title":"President, Chief Executive Officer &amp; Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}